Potential regulatory role of the farnesoid X receptor in the metabolic syndrome

  • Duran-Sandoval D
  • Cariou B
  • Fruchart J
 et al. 
  • 0

    Readers

    Mendeley users who have this article in their library.
  • 25

    Citations

    Citations of this article.

Abstract

Dyslipidemia and gallbladder diseases are two current anomalies observed in patients suffering from the metabolic syndrome and type 2 diabetes. The bile acid-activated nuclear receptor farnesoid X receptor (FXR) controls bile acid as well as lipid metabolism. Recent observations indicate a role for FXR also in carbohydrate metabolism. Hepatic FXR expression is altered in diabetic animal models in vivo and regulated by hormones and nutrients in vitro. At the molecular level, FXR activation modifies the transcriptional activity of different transcription factors controlling gluconeogenesis and lipogenesis, thus affecting in concert bile acid, lipid and carbohydrate metabolism. The present review focuses on recent advances in our understanding of the modulation of carbohydrate metabolism by FXR. These observations raise the intriguing possibility for a modulatory role of this receptor also in the metabolic syndrome. © 2005 Elsevier SAS. All rights reserved.

Author-supplied keywords

  • FXR
  • Gluconeogenesis
  • Insulin resistance
  • Metabolic syndrome
  • SHP

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text

Authors

  • Daniel Duran-Sandoval

  • Bertrand Cariou

  • Jean Charles Fruchart

  • Bart Staels

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free